TFIIH p52 Antibodies

Santa Cruz Biotechnology delivers a wide array of TFIIH p52 monoclonal antibodies for research focused on understanding cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).TFIIH p52 is a critical component of the transcription factor IIH complex, which is involved in DNA repair and transcription initiation. TFIIH p52 plays a vital role in the nucleotide excision repair pathway, helping to maintain genomic stability by repairing DNA damage caused by environmental factors. Additionally, TFIIH p52 is implicated in the regulation of gene expression, making it an important target for studies related to cancer and other diseases. TFIIH p52 has been found to interact with multiple proteins within the transcription complex, facilitating proper assembly and function. Research has shown that mutations in TFIIH p52 can lead to various developmental disorders and increased susceptibility to certain cancers. Understanding TFIIH p52's role in cellular pathways continues to reveal new insights into disease mechanisms and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TFIIH p52's role in health and disease.